Clinical Trial

" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by diverse clinical manifestations, prominently involving the skin.
Trial Details
NCT Number NCT07397728
Lead Sponsor South Valley University
Conditions Systemic Lupus Erythematosus
Enrollment 90 participants
Start Date 2025-06-10
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-09